Literature DB >> 16420250

Inhibitory effect of piperlonguminine on melanin production in melanoma B16 cell line by downregulation of tyrosinase expression.

Kyeong-Soo Kim1, Jeong Ah Kim, Seung-Yong Eom, Seung Ho Lee, Kyung Rak Min, Youngsoo Kim.   

Abstract

Tyrosinase is a key enzyme for melanin biosynthesis, and hyperpigmentation disorders are associated with abnormal accumulation of melanin pigments, which can be improved by treatment with depigmenting agents. In the present study, piperlonguminine from Piper longum was discovered to inhibit melanin production in melanoma B16 cells stimulated with alpha-melanocyte stimulating hormone (alpha-MSH), 3-isobutyl-1-methylxanthine or protoporphyrin IX, where the compound exhibited stronger depigmenting efficacy than kojic acid. However, piperlonguminine did not affect 1-oleoyl-2-acetyl-sn-glycerol-induced melanogenesis and did not affect protein kinase C-mediated melanin production. Surprisingly, piperlonguminine did not inhibit the catalytic activity of cell-free tyrosinase from melanoma B16 cells but rather suppressed tyrosinase mRNA expression. This effect was attributed to the inhibitory action of piperlonguminine on alpha-MSH-induced signaling through cAMP to the cAMP responsive element binding protein that in turn regulates the expression of the microphthalmia-associated transcription factor, a key activator of the tyrosinase promoter. This study demonstrates that piperlonguminine is an efficient depigmenting agent with a novel mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16420250     DOI: 10.1111/j.1600-0749.2005.00281.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  19 in total

1.  Suppression of melanin production by expression of HSP70.

Authors:  Tatsuya Hoshino; Minoru Matsuda; Yasuhiro Yamashita; Masaya Takehara; Masayo Fukuya; Kazutaka Mineda; Daisuke Maji; Hironobu Ihn; Hiroaki Adachi; Gen Sobue; Yoko Funasaka; Tohru Mizushima
Journal:  J Biol Chem       Date:  2010-02-22       Impact factor: 5.157

2.  Piperlonguminine downregulates endothelial protein C receptor shedding in vitro and in vivo.

Authors:  Sae-Kwang Ku; Jeong Ah Kim; Jong-Sup Bae
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

3.  Anticholinesterase and antityrosinase activities of ten piper species from malaysia.

Authors:  Wan Mohd Nuzul Hakimi Wan Salleh; Nur Athirah Hashim; Farediah Ahmad; Khong Heng Yen
Journal:  Adv Pharm Bull       Date:  2014-12-31

4.  Occurrence of piperidine alkaloids in Piper species collected in different areas.

Authors:  Narisu Bao; Sarangowa Ochir; Zhaorigetu Sun; Gereltu Borjihan; Takashi Yamagishi
Journal:  J Nat Med       Date:  2013-04-27       Impact factor: 2.343

5.  Vascular barrier protective effects of piperlonguminine in vitro and in vivo.

Authors:  Sae-Kwang Ku; Jeong Ah Kim; Jong-Sup Bae
Journal:  Inflamm Res       Date:  2014-01-29       Impact factor: 4.575

Review 6.  The hunt for natural skin whitening agents.

Authors:  Nico Smit; Jana Vicanova; Stan Pavel
Journal:  Int J Mol Sci       Date:  2009-12-10       Impact factor: 6.208

7.  Synthesis of regiospecifically fluorinated conjugated dienamides.

Authors:  Mohammad Chowdhury; Samir K Mandal; Shaibal Banerjee; Barbara Zajc
Journal:  Molecules       Date:  2014-04-10       Impact factor: 4.411

Review 8.  In vitro techniques to assess the proficiency of skin care cosmetic formulations.

Authors:  Amit Roy; Ram Kumar Sahu; Munglu Matlam; Vinay Kumar Deshmukh; Jaya Dwivedi; Arvind Kumar Jha
Journal:  Pharmacogn Rev       Date:  2013-07

9.  Anticoagulant activities of piperlonguminine in vitro and in vivo.

Authors:  Wonhwa Lee; Hayoung Yoo; Sae-Kwang Ku; Jeong Ah Kim; Jong-Sup Bae
Journal:  BMB Rep       Date:  2013-10       Impact factor: 4.778

10.  Piperlongumine Blocks JAK2-STAT3 to Inhibit Collagen-Induced Platelet Reactivity Independent of Reactive Oxygen Species.

Authors:  Hengjie Yuan; Katie L Houck; Ye Tian; Uddalak Bharadwaj; Ken Hull; Zhou Zhou; Mingzhao Zhu; Mingzhao Zhou; Xiaoping Wu; David J Tweardy; Daniel Romo; Xiaoyun Fu; Yanjun Zhang; Jianning Zhang; Jing-fei Dong
Journal:  PLoS One       Date:  2015-12-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.